
|Articles|February 6, 2019
Sharp Invests More into Enhancing IRT Solution
Advertisement
Sharp-part of UDG Healthcare plc, a global company in contract packaging and clinical supply services-announced that it is investing $650,000 into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots, and investigative sites.
To read the full release, click
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where AI Is Delivering Real Value in Clinical Trial Payments Right Now
2
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
3
ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise
4
How Urgent Is the Site Payment Problem, and Is the Industry Finally Taking It Seriously?
5




